MedTrace Logo

Technology and Human Help at Home After Hospitalisation

NCT02335177 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2017-05-30

No results posted yet for this study

Summary

Elderly people are still at risk for falling at home. The objective of the study is to evaluate at home the impact of an intervention for 3 months combining technologies for autonomy and tailored physical activity program. The study is performed among patients aged 75 years and over leaving Charles Foix Geriatrics hospital or already supported by carer of professional home-care service Ages \& Vie and with a loss of autonomy requiring physiotherapy and home support workers. It is a prospective, randomized, single-center, in cluster study which compares a Patient group (interventional group) with the intervention program (technologies + physical activities) with a control group benefiting from usual care home. Our hypothesis is that in the interventional group fewer falls were observed and improved different scores (Timed Up and Go Test,Barthel index, Quality of Life questionnaire of Duke) were reported compared to the control group.

Conditions

  • Patient Fall

Interventions

BEHAVIORAL

Interventional arm

At home patients have both technologies for autonomy (walkers, treadmill) and tailored physical activity program performed with the help of the home carer. Intervention takes 3 months. Assessment at hospital discharge et at 3 months.

Sponsors & Collaborators

  • Caisse Nationale de Solidarité pour l'Autonomie

    collaborator OTHER

  • National Insurance Fund Vieilleisse

    collaborator OTHER

  • Réunica

    collaborator UNKNOWN

  • Fondation Macif

    collaborator UNKNOWN

  • Ages et Vies Association

    lead OTHER

Principal Investigators

  • Meziere Anthony, Dr · Hôpital Charles Foix, AP-HP

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-10-31
Completion
2016-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02335177 on ClinicalTrials.gov